The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Vaxcyte Inc shares valued at $353,699 were sold by Eydelman Mikhail on Mar 05 ’25. At $70.74 per share, Eydelman Mikhail sold 5,000 shares. The insider’s holdings dropped to 41,620 shares worth approximately $1.28 million following the completion of this transaction.
Also, Eydelman Mikhail purchased 5,000 shares, netting a total of over 344,350 in proceeds.
Before that, Wassil Jim had sold 8,000 shares from its account. In a trade valued at $586,165, the CHIEF OPERATING OFFICER traded Vaxcyte Inc shares for $73.27 each. Upon closing the transaction, the insider’s holdings decreased to 8,000 shares, worth approximately $4.77 million.
As published in their initiating research note from Cantor Fitzgerald on April 22, 2025, Vaxcyte Inc [PCVX] has been an Overweight. Analysts at Goldman started covering the stock with ‘”a Buy”‘ outlook in a report released in mid December. As of December 07, 2023, Mizuho has initiated its “Buy” rating for PCVX. Earlier on April 18, 2023, TD Cowen initiated its rating. Their recommendation was “an Outperform” for PCVX stock.
Analyzing PCVX Stock Performance
On last trading session, Vaxcyte Inc [NASDAQ: PCVX] rose 0.72% to $30.77. The stock’s lowest price that day was $30.44, but it reached a high of $31.44 in the same session. During the last five days, there has been a drop of approximately -3.57%. Over the course of the year, Vaxcyte Inc shares have dropped approximately -61.29%. Shares of the company reached a 52-week high of $93.77 on 01/28/25 and a 52-week low of $27.66 on 04/10/25.
Support And Resistance Levels for Vaxcyte Inc (PCVX)
According to the 24-hour chart, there is a support level at 30.33, which, if violated, would cause prices to drop to 29.88. In the upper region, resistance lies at 31.33. The next price resistance is at 31.88. RSI (Relative Strength Index) is 41.86 on the 14-day chart, showing neutral technical sentiment.
Is Vaxcyte Inc subject to short interest?
Stocks of Vaxcyte Inc saw a sharp steep in short interest on 2025-08-15 dropping by -2.18 million shares to 11.44 million. Data from Yahoo Finance shows that the short interest on 2025-07-15 was 13.62 million shares. A decline of -19.09% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 8.72 of the overall float, the days-to-cover ratio (short ratio) decline to 8.72.
Which companies own the most shares of Vaxcyte Inc (PCVX)?
In terms of Vaxcyte Inc share price expectations, FactSet research, analysts set an average price target of 140 in the next 12 months, up nearly 358.27% from the previous closing price of $30.55. Analysts anticipate Vaxcyte Inc stock to reach 163 by 2025, with the lowest price target being 58. In spite of this, 6 analysts ranked Vaxcyte Inc stock as Buy at the end of 2025. On January 03, 2023, Needham assigned a price target of “a Buy” to the stock and reiterated coverage with a $58.
